SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-20-014268
Filing Date
2020-06-19
Accepted
2020-06-19 09:00:42
Documents
13

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 425 101279
2 EXHIBIT 2.1 ex2_1.htm EX-2.1 788038
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 172861
4 EXHIBIT 4.2 ex4_2.htm EX-4.2 230304
5 EXHIBIT 10.1 ex10_1.htm EX-10.1 115023
6 EXHIBIT 10.2 ex10_2.htm EX-10.2 58822
7 EXHIBIT 10.3 ex10_3.htm EX-10.3 23758
8 EXHIBIT 10.4 ex10_4.htm EX-10.4 609614
9 EXHIBIT 10.5 ex10_5.htm EX-10.5 20240
10 EXHIBIT 10.6 ex10_6.htm EX-10.6 20208
11 EXHIBIT 99.1 ex99_1.htm EX-99.1 26165
12 image00002.jpg GRAPHIC 4322
13 image00003.jpg GRAPHIC 4625
  Complete submission text file 0001140361-20-014268.txt   2180641
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filed by) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Subject) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-34079 | Film No.: 20974381
SIC: 2834 Pharmaceutical Preparations